I agree wholeheartedly with the criticism of the way the Conly Cochrane meta-analysis dismissive of masks has been conducted. But—sorry, team—I need to add some wee quibbles from a philosophy of science perspective. 🧵theconversation.com/yes-masks-redu…
The biggest shortcoming of RCTs of respirators is this: where direct mechanistic evidence retains predictive validity, this is the preferred form of scientific evidence. The invalidity of direct mechanistic modelling needs to be proven before falling back on RCTs.
Look at the key occupational PPE worn by this soldier: tactical respirator, helmet, body armour. None are tested by RCT. Some non-clinicians sitting in an office demand RCTs before the *same gear* can be issued to HCW before going into battle against COVID. Image
Let's look at the filtration component of a military tactical respirator. It protects against the inhalation of hazardous gasses and bioaerosols in chemical and biological warfare. Here is a 3M HF-800 half-mask, which can do much the same thing. Image
Here are the filter options for the @3MSafety HF-800SD series sold on Amazon. Even the filter for chemical vapours is NIOSH P100 rated against particulates (like asbestos) and bioaerosols. A military tactical respirator is a minor variation of a medical bioaerosol respirator. Image
Let's take a closer look at that military tactical respirator. You can make out faint EU CE certification markings, probably similar (if not the exact same) CE markings as those conferred to non-military elastomerics. Image
An elastomeric respirator goes through the same bioaerosol and particulate testing protocols based on EU CE standards as a disposable FFP2 or FFP3 respirator. The physicochemical principles by which they work are also identical. Image
We don't expect military helmets and body armour to be live tested vs placebo before being declared worthy of issue as military PPE. Nor do we expect military tactical respirators to be live tested vs placebo in a gas or biowarfare attack, prior to becoming standard issue.
Or are we to believe that the toxic vapour filtration (for chemical warfare) and the bioaerosol filtration (for biological warfare) of the *same* NIOSH/CE certified filter should be tested by different standards? One by direct mechanistic testing, the other by clinical RCT?
As with crash-testing helmets, there is no reason that laboratory testing of respirators does not accurately predict outcomes in the real world. Because evidence gained from direct mechanistic modelling retains predictive validity for the real world. helmet.beam.vt.edu
Bioaerosols behave according to the predictive laws of physics. In-laboratory direct mechanistic testing of a respirator can be demonstrated to be predictive of protection against airborne bioaerosols. It is unethical to subject wearers to live RCT testing in biowarfare.
Testing in real-world RCT settings is more likely to introduce confounding from compliance and deployment training issues. If soldiers died before donning respirators in a Novichok attack in Ukraine, would you declare surgical masks just as effective as tactical respirators?
The likes of Conly are useless academics who sit in an office trying to get us frontline HCWs killed and injured by hindering universal access to correct PPE. They have blood on their hands. Thousands of HCWs have suffered from such incompetence.
The majority of science is done by predictive corroborative testing of direct mechanistic modelling without RCTs. For example, Einstein's general theory of relativity predicted gravity waves which took decades before they were definitively confirmed. ligo.caltech.edu/page/what-are-…
Medicine is the black sheep of science, as predictive modelling of drug efficacy is not yet valid. We can't design drugs with direct mechanistic modelling like engineers design bridges. We are reduced to primitive trial-and-error empiricism to see if a drug kills or cures.
In most sciences, direct mechanistic modelling retains predictive validity. We can't generalise from its invalidity in medicine to think the same limitations of predictive modelling apply to aerosol physics, which is judged by the evidence standards of physics, not pharmacology.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Satoshi Akima FRACP 『秋間聰』

Dr Satoshi Akima FRACP 『秋間聰』 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ToshiAkima

Oct 19
I was always suspicious of the thousands of freshly minted clichéd Canadian trucker convoy and MAGA accounts pushing anti-vaxx propaganda. You'd block a thousand only to have a thousand more appear. They'd all repeat the same set of messages over and over.
We clinicians are naive. All we could do in reply to the misinformation campaign was quote some RCT as though it were a scientific debate, when really it was an act of war. Yes, a proxy war waged by atypical means, but a war nonetheless.
As they got the UK to shoot itself in the foot with Brexit, the troll farms politicised the bipartisan issue of vaccination. The result was a civil war waged with biological agents, causing an enormous mortality disparity between left and right.
Read 6 tweets
Aug 29
The paper is now out in @Nature after I tweeted on this oral presentation @ISTH 2023 by @AkassoglouLab. Fibrin/fibrinogen may be a therapeutic target in СОVΙD neuropathology. Link in next tweet.
“...results reveal a role for fibrinogen as a SARS-CoV-2 spike-binding protein accelerating the formation of abnormal clots with increased inflammatory activity”…“fibrin-targeting immunotherapy suppresses SARS-CoV-2 pathogenesis”.

Image
Image
From an #immunothrombosis perspective, this paper now shows fibrinogen to be a far more critical player in this field than previously thought. We used to focus more on contact, TF, and thrombin but now must look further downstream in the fibrinogenesis/fibrinolysis pathways too.
Read 7 tweets
Aug 8
It's not so bad a comparison if you accept that to get a similar “depletion of the susceptibles” by a Darwinian evolutionary mechanism, you'd have to deplete 2-400M vulnerable pheno-/genotypes from the pool.
It's always assumed that “evolve to become milder” means that the virus evolves, when it is just as likely that humans are “evolving” via a survival mechanism involving “depletion of the susceptibles”, leaving only those less prone to a lethal outcome. This, too, is evolution.
GBD types would likely argue that intervention to halt the depletion of the susceptibles is a perversion of the natural selection process and a crime. By opposing it, we are simply prolonging the pandemic.
Read 11 tweets
Aug 5
And this week's Grand Rounds “just a cold” is another young patient with enterovirus-induced fulminant myocarditis needing intubation, ECMO, and an Impella LVAD. I've never seen so many severe post-infectious complications presented in my life.
Last week's Grand Round? Another “just a cold” with Mycoplasma in a paediatric patient who developed encephalopathy, needing IV pulse methylprednisolone and IVIg. It's like every week we see a new case of previously rare infectious complications in young patients.
Another Grand Rounds case. A pregnant woman with severe cardiomyopathy caused by a combined adenovirus and enterovirus infections. Required ECMO.
Read 4 tweets
Aug 3
Subjecting trial subjects to wearing surgical mаsks against an airborne virus is like running a bike helmet RCT with subjects in Tupperware helmets that weren't designed for that purpose. “But we don't know it doesn't work until we run an RCT” isn't good enough.
Image
“But there was a 30% reduction in head injuries in the Tupperware group vs. placebo.” Not good enough! In a high-risk scenario for major head injury, a Tupperware helmet won't do. The magnitude of risk test subjects were exposed to needs investigation and quantification. Image
Non-pharmaceutical physical protective devices are subject to engineering standards of proof of efficacy. In the case of helmets, that means crash testing in a lab to see how they fare in high-risk situations that live subjects can't be exposed to. helmet.beam.vt.edu/lab.html
Image
Read 7 tweets
Jul 31
A reminder that there was once a titanic struggle between contagionists vs miasmatists over the mechanism of transmission of cholera before the need to cleanse the water of waterborne pathogens was accepted. We are going through a similar struggle today, fighting for clean air. abc.net.au/news/2024-07-3…
If you want to read about how divisive the debates between the contagionists and miasmatists was, you should read “Death in Hamburg” by @RichardEvans36. They didn't need Twitter back then to be almost reduced to pistols at dawn.
Quoted in the article by @Hayley_Gleeson is our latter-day Professor Pettenkofer from Down Under: “I want to believe…”
Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(